Trial · NCT02230670
Adverse events58
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 58
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | abdominal pain | Gastrointestinal disorders | IDN-6556 (Baseline-Month 3) | 3 | 44 | 3 |
| other | abdominal pain | Gastrointestinal disorders | Placebo (Baseline-Month 3) | 3 | 42 | 3 |
| other | arthralgia | General disorders | IDN-6556 (Baseline-Month 3) | 3 | 44 | 3 |
| other | arthralgia | General disorders | Placebo (Baseline-Month 3) | 0 | 42 | 0 |
| other | ascites | Gastrointestinal disorders | IDN-6556 (Baseline-Month 3) | 1 | 44 | 2 |
| other | ascites | Gastrointestinal disorders | Placebo (Baseline-Month 3) | 3 | 42 | 3 |
| other | fatigue | Metabolism and nutrition disorders | IDN-6556 (Baseline-Month 3) | 4 | 44 | 4 |
| other | fatigue | Metabolism and nutrition disorders | Placebo (Baseline-Month 3) | 6 | 42 | 7 |
| other | headache | Nervous system disorders | IDN-6556 (Baseline-Month 3) | 7 | 44 | 8 |
| other | headache | Nervous system disorders | Placebo (Baseline-Month 3) | 3 | 42 | 4 |
| other | hepatic encephalopathy | Nervous system disorders | IDN-6556 (Baseline-Month 3) | 5 | 44 | 7 |
| other | hepatic encephalopathy | Nervous system disorders | Placebo (Baseline-Month 3) | 2 | 42 | 3 |
| other | muscle spasms | Musculoskeletal and connective tissue disorders | IDN-6556 (Baseline-Month 3) | 0 | 44 | 0 |
| other | muscle spasms | Musculoskeletal and connective tissue disorders | Placebo (Baseline-Month 3) | 3 | 42 | 3 |
| other | nausea | Gastrointestinal disorders | IDN-6556 (Baseline-Month 3) | 7 | 44 | 8 |
| other | nausea | Gastrointestinal disorders | Placebo (Baseline-Month 3) | 4 | 42 | 5 |
| other | oedema peripheral | Blood and lymphatic system disorders | IDN-6556 (Baseline-Month 3) | 1 | 44 | 1 |
| other | oedema peripheral | Blood and lymphatic system disorders | Placebo (Baseline-Month 3) | 4 | 42 | 4 |
| other | urinary tract infection | Infections and infestations | IDN-6556 (Baseline-Month 3) | 3 | 44 | 3 |
| other | urinary tract infection | Infections and infestations | Placebo (Baseline-Month 3) | 1 | 42 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02230670/events